Protalix Biotherapeutics Inc (PLX)
Depreciation & Amortization
$406.00K
Quarterly · Period ending: · USD
PLX Depreciation & Amortization
Latest reported$406.00Kperiod ending
Latest reported$406.00Kperiod ending
PLX Quarterly Depreciation & Amortization ($0.00 → $406.00K)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
PLX depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 406,000 | |
| 404,000 | |
| 387,000 | |
| 372,000 | |
| 360,000 | |
| 346,000 | |
| 334,000 | |
| 329,000 | |
| 319,000 | |
| 322,000 | |
| 313,000 | |
| 305,000 | |
| 293,000 | |
| 280,000 | |
| 275,000 | |
| 273,000 | |
| 268,000 | |
| 270,000 | |
| 259,000 | |
| 285,000 | |
| 288,000 | |
| 286,000 | |
| 291,000 | |
| 301,000 | |
| 334,000 | |
| 376,000 | |
| 412,000 | |
| 421,000 | |
| 379,000 | |
| 405,000 | |
| 414,000 | |
| 411,000 | |
| 416,000 | |
| 430,000 | |
| 451,000 | |
| 483,000 | |
| 494,000 | |
| 492,000 | |
| 494,000 | |
| 483,000 | |
| 490,000 | |
| 516,000 | |
| 559,000 | |
| 588,000 | |
| 607,000 | |
| 616,000 | |
| 722,000 | |
| 790,000 | |
| 800,000 | |
| 828,000 | |
| 850,000 | |
| 871,000 | |
| 892,000 | |
| 926,000 | |
| 920,000 | |
| 912,000 | |
| 930,000 | |
| 930,000 | |
| 933,000 | |
| 897,000 | |
| 923,000 | |
| 878,000 | |
| 889,000 | |
| 789,000 | |
| 758,000 | |
| 697,000 | |
| 583,000 | |
| 478,000 | |
| 474,000 | |
| 455,000 | |
| 374,000 | |
| 345,000 | |
| 320,000 | |
| 262,000 | |
| 229,000 | |
| 253,000 | |
| 145,000 | |
| 132,000 | |
| 502,000 | |
| 111,000 | |
| 105,000 | |
| 98,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |